Uterine leiomyosarcoma is a rare and aggressive cancer that occurs in the uterus. Individuals usually require a hysterectomy. Treatments can also include chemotherapy or radiotherapy. Leiomyosarcoma ...

Clinical Trials for Leiomyosarcoma New clinical trials come up depending on what cancer researchers are working on. Some of the current ones for leiomyosarcoma are for a type of treatment called ...

Soft Tissue and Uterine Leiomyosarcoma The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held ...

Uterine leiomyosarcoma is a rare form of cancer. The earlier uterine leiomyosarcoma is diagnosed, the better the outlook. Uterine leiomyosarcoma accounts for 2–5% of all uterine cancers. It starts in ...

Once your treatment is done, your oncologist may tell you that your leiomyosarcoma is in “remission.” This means that signs of your cancer have faded or disappeared. But that doesn’t mean you’re ...

Patients were randomly assigned in a 2:1 ratio to receive trabectedin or dacarbazine intravenously every 3 weeks. The primary end point was overall survival (OS), secondary end points were disease ...

Leiomyosarcoma is a type of soft tissue sarcoma that is hard to treat and associated with a poor prognosis. Scientists at the Institute of Cancer Research are working to better understand the biology ...

Editor's Note: Uterine leiomyosarcomas are aggressive, heterogeneous cancers associated with high rates of progression and recurrence—and poor outcome. Uterine sarcomas as a group are uncommon cancers ...

Inflammatory leiomyosarcoma, first described by Merchant et al., 1 is a spindle cell tumor of the deep soft tissues that shares morphological features with conventional leiomyosarcoma but that also ...

The benefit will offer raffles and a spaghetti and chicken dinner.

A new case report was published in Volume 17 of Oncotarget on May 4, 2026, titled “Laryngeal leiomyosarcoma: A rare case ...